LEADING BIOTECH FIRM REPLACES VPN WITH ZTNA TO SECURE ACCESS TO BUSINESS- CRITICAL APPS AND SENSITIVE DATA

1 Pages

Appgate helped the biotech company secure connections across its complex IT estate—including physical labs, office networks, and cloud systems—by implementing a Zero Trust Network Access (ZTNA) solution. This enhanced visibility and control reduced security risks, protected sensitive research environments, and ensured secure, seamless access for users. Appgate’s platform supported the company’s mission to advance precision medicine by safeguarding critical data and enabling trusted connectivity across diverse and distributed operations.

Join for free to read

Ebook Zscaler Private Access

Guide Universal ZTNA: The Practitioner’s Handbook

Ebook Want to Secure Your Hybrid Workforce with ZTNA?

Case Study How Lantum, a Workforce Platform for Healthcare Organizations,…

More from AppGate

Case Study CONVOSO REPLACES HARDWARE VPN WITH ZERO TRUST NETWORK ACCESS TO…

Case Study PUBLISHER REPLACES VPN, ENERGIZES “FAST PIVOT” TO REMOTE WORK

Case Study PUBLISHING FIRM SWITCHES FROM LEGACY VPN TO RESILIENT REMOTE…

Case Study CONVOSO REPLACES HARDWARE VPN WITH ZERO TRUST NETWORK ACCESS TO…

Case Study

LEADING BIOTECH FIRM REPLACES VPN WITH ZTNA TO SECURE ACCESS TO BUSINESS- CRITICAL APPS AND SENSITIVE DATA

LEADING BIOTECH FIRM REPLACES VPN WITH ZTNA TO SECURE ACCESS TO BUSINESS- CRITICAL APPS AND SENSITIVE DATA

You Might Also Like

More from AppGate